Overexpression of KiSS1 Induces the Proliferation of Hepatocarcinoma and Increases Metastatic Potential by Increasing Migratory Ability and Angiogenic Capacity |
Cho-Won, Kim
(Laboratory of Biochemistry and Immunology, College of Veterinary Medicine, Chungbuk National University)
Hong, Kyu, Lee (Laboratory of Biochemistry and Immunology, College of Veterinary Medicine, Chungbuk National University) Min-Woo, Nam (Laboratory of Biochemistry and Immunology, College of Veterinary Medicine, Chungbuk National University) Youngdong, Choi (Laboratory of Biochemistry and Immunology, College of Veterinary Medicine, Chungbuk National University) Kyung-Chul, Choi (Laboratory of Biochemistry and Immunology, College of Veterinary Medicine, Chungbuk National University) |
1 | Bhardwaj, B., Bhardwaj, G., and Lau, J.Y. (1999). Expression of p21 and p27 in hepatoma cell lines with different p53 gene profile. J. Hepatol. 31, 386. |
2 | Bielenberg, D.R. and Zetter, B.R. (2015). The contribution of angiogenesis to the process of metastasis. Cancer J. 21, 267-273. DOI |
3 | Bisteau, X., Caldez, M.J., and Kaldis, P. (2014). The complex relationship between liver cancer and the cell cycle: a story of multiple regulations. Cancers (Basel) 6, 79-111. DOI |
4 | Bosmuller, H., Pfefferle, V., Bittar, Z., Scheble, V., Horger, M., Sipos, B., and Fend, F. (2018). Microvessel density and angiogenesis in primary hepatic malignancies: Differential expression of CD31 and VEGFR-2 in hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Pathol. Res. Pract. 214, 1136-1141. DOI |
5 | Brabletz, T., Kalluri, R., Nieto, M.A., and Weinberg, R.A. (2018). EMT in cancer. Nat. Rev. Cancer 18, 128-134. DOI |
6 | Carvalho, J.R., Fortunato, I.C., Fonseca, C.G., Pezzarossa, A., Barbacena, P., Dominguez-Cejudo, M.A., Vasconcelos, F.F., Santos, N.C., Carvalho, F.A., and Franco, C.A. (2019). Non-canonical Wnt signaling regulates junctional mechanocoupling during angiogenic collective cell migration. Elife 8, e45853. |
7 | Chang, F., Lee, J.T., Navolanic, P.M., Steelman, L.S., Shelton, J.G., Blalock, W.L., Franklin, R.A., and McCubrey, J.A. (2003). Involvement of PI3K/ Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy. Leukemia 17, 590-603. DOI |
8 | Clarke, H., Dhillo, W.S., and Jayasena, C.N. (2015). Comprehensive review on kisspeptin and its role in reproductive disorders. Endocrinol. Metab. (Seoul) 30, 124-141. DOI |
9 | Colecchia, A., Schiumerini, R., Cucchetti, A., Cescon, M., Taddia, M., Marasco, G., and Festi, D. (2014). Prognostic factors for hepatocellular carcinoma recurrence. World J. Gastroenterol. 20, 5935-5950. DOI |
10 | Delire, B., Henriet, P., Lemoine, P., Leclercq, I.A., and Starkel, P. (2018). Chronic liver injury promotes hepatocarcinoma cell seeding and growth, associated with infiltration by macrophages. Cancer Sci. 109, 2141-2152. DOI |
11 | Dhanasekaran, R., Bandoh, S., and Roberts, L.R. (2016). Molecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advances. F1000Res. 5, F1000 Faculty Rev-879. |
12 | Eferl, R., Ricci, R., Kenner, L., Zenz, R., David, J.P., Rath, M., and Wagner, E.F. (2003). Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53. Cell 112, 181-192. DOI |
13 | Fan, B., Yu, Y., and Zhang, Y. (2015). PI3K-Akt1 expression and its significance in liver tissues with chronic fluorosis. Int. J. Clin. Exp. Pathol. 8, 1226-1236. |
14 | Ghanekar, A., Ahmed, S., Chen, K., and Adeyi, O. (2013). Endothelial cells do not arise from tumor-initiating cells in human hepatocellular carcinoma. BMC Cancer 13, 485. |
15 | Global Burden of Disease Liver Cancer Collaboration, Akinyemiju, T., Abera, S., Ahmed, M., Alam, N., Alemayohu, M.A., Allen, C., Al-Raddadi, R., Alvis-Guzman, N., Amoako, Y., et al. (2017). The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the Global Burden of Disease study 2015. JAMA Oncol. 3, 1683-1691. DOI |
16 | Glumac, P.M. and LeBeau, A.M. (2018). The role of CD133 in cancer: a concise review. Clin. Transl. Med. 7, 18. |
17 | Imamura, H., Matsuyama, Y., Tanaka, E., Ohkubo, T., Hasegawa, K., Miyagawa, S., Sugawara, Y., Minagawa, M., Takayama, T., Kawasaki, S., et al. (2003). Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J. Hepatol. 38, 200-207. |
18 | Go, R.E., Kim, C.W., Jeon, S.Y., Byun, Y.S., Jeung, E.B., Nam, K.H., and Choi, K.C. (2017). Fludioxonil induced the cancer growth and metastasis via altering epithelial-mesenchymal transition via an estrogen receptordependent pathway in cellular and xenografted breast cancer models. Environ. Toxicol. 32, 1439-1454. DOI |
19 | He, S. and Tang, S. (2020). WNT/beta-catenin signaling in the development of liver cancers. Biomed. Pharmacother. 132, 110851. |
20 | Ikeguchi, M., Hirooka, Y., and Kaibara, N. (2003). Quantitative reverse transcriptase polymerase chain reaction analysis for KiSS-1 and orphan G-protein-coupled receptor (hOT7T175) gene expression in hepatocellular carcinoma. J. Cancer Res. Clin. Oncol. 129, 531-535. DOI |
21 | Kalluri, R. and Weinberg, R.A. (2009). The basics of epithelial-mesenchymal transition. J. Clin. Invest. 119, 1420-1428. DOI |
22 | Kauffman, A.S. (2009). Sexual differentiation and the Kiss1 system: hormonal and developmental considerations. Peptides 30, 83-93. DOI |
23 | Kim, C.W. and Choi, K.C. (2021). Potential roles of iridoid glycosides and their underlying mechanisms against diverse cancer growth and metastasis: do they have an inhibitory effect on cancer progression? Nutrients 13, 2974. DOI |
24 | Kim, C.W., Go, R.E., Lee, G.A., Kim, C.D., Chun, Y.J., and Choi, K.C. (2016a). Immortalization of human corneal epithelial cells using simian virus 40 large T antigen and cell characterization. J. Pharmacol. Toxicol. Methods 78, 52-57. DOI |
25 | Kummar, S. and Shafi, N.Q. (2003). Metastatic hepatocellular carcinoma. Clin. Oncol. (R. Coll. Radiol.) 15, 288-294. DOI |
26 | Kim, C.W., Hwang, K.A., and Choi, K.C. (2016b). Anti-metastatic potential of resveratrol and its metabolites by the inhibition of epithelialmesenchymal transition, migration, and invasion of malignant cancer cells. Phytomedicine 23, 1787-1796. DOI |
27 | Kim, C.W., Kim, C.D., and Choi, K.C. (2017a). Establishment and evaluation of immortalized human epidermal keratinocytes for an alternative skin irritation test. J. Pharmacol. Toxicol. Methods 88, 130-139. DOI |
28 | Kim, C.W., Lee, H.M., Lee, K., Kim, B., Lee, M.Y., and Choi, K.C. (2017b). Effects of cigarette smoke extracts on cell cycle, cell migration and endocrine activity in human placental cells. Reprod. Toxicol. 73, 8-19. DOI |
29 | Lamouille, S., Xu, J., and Derynck, R. (2014). Molecular mechanisms of epithelial-mesenchymal transition. Nat. Rev. Mol. Cell Biol. 15, 178-196. DOI |
30 | Leal-Esteban, L.C. and Fajas, L. (2020). Cell cycle regulators in cancer cell metabolism. Biochim. Biophys. Acta Mol. Basis Dis. 1866, 165715. |
31 | Lee, H.K., Shin, H.J., Koo, J., Kim, T.H., Kim, C.W., Go, R.E., Seong, Y.H., Park, J.E., and Choi, K.C. (2021). Blockade of transforming growth factor beta2 by anti-sense oligonucleotide improves immunotherapeutic potential of IL-2 against melanoma in a humanized mouse model. Cytotherapy 23, 599-607. DOI |
32 | Lee, J.H., Miele, M.E., Hicks, D.J., Phillips, K.K., Trent, J.M., Weissman, B.E., and Welch, D.R. (1996). KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. J. Natl. Cancer Inst. 88, 1731-1737. DOI |
33 | Liou, G.Y. (2019). CD133 as a regulator of cancer metastasis through the cancer stem cells. Int. J. Biochem. Cell Biol. 106, 1-7. DOI |
34 | Lee, J.H. and Welch, D.R. (1997a). Identification of highly expressed genes in metastasis-suppressed chromosome 6/human malignant melanoma hybrid cells using subtractive hybridization and differential display. Int. J. Cancer 71, 1035-1044. DOI |
35 | Lee, J.H. and Welch, D.R. (1997b). Suppression of metastasis in human breast carcinoma MDA-MB-435 cells after transfection with the metastasis suppressor gene, KiSS-1. Cancer Res. 57, 2384-2387. |
36 | Liang, J., Zubovitz, J., Petrocelli, T., Kotchetkov, R., Connor, M.K., Han, K., Lee, J.H., Ciarallo, S., Catzavelos, C., Beniston, R., et al. (2002). PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27- mediated G1 arrest. Nat. Med. 8, 1153-1160. DOI |
37 | Liu, X., Liao, W., Yuan, Q., Ou, Y., and Huang, J. (2015). TTK activates Akt and promotes proliferation and migration of hepatocellular carcinoma cells. Oncotarget 6, 34309-34320. DOI |
38 | Llovet, J.M., Kelley, R.K., Villanueva, A., Singal, A.G., Pikarsky, E., Roayaie, S., Lencioni, R., Koike, K., Zucman-Rossi, J., and Finn, R.S. (2021). Hepatocellular carcinoma. Nat. Rev. Dis. Primers 7, 6. |
39 | Loh, C.Y., Chai, J.Y., Tang, T.F., Wong, W.F., Sethi, G., Shanmugam, M.K., Chong, P.P., and Looi, C.Y. (2019). The E-cadherin and N-cadherin switch in epithelial-to-mesenchymal transition: signaling, therapeutic implications, and challenges. Cells 8, 1118. |
40 | Lu, Y., Lin, N., Chen, Z., and Xu, R. (2015). Hypoxia-induced secretion of platelet-derived growth factor-BB by hepatocellular carcinoma cells increases activated hepatic stellate cell proliferation, migration and expression of vascular endothelial growth factor-A. Mol. Med. Rep. 11, 691-697. DOI |
41 | Morse, M.A., Sun, W., Kim, R., He, A.R., Abada, P.B., Mynderse, M., and Finn, R.S. (2019). The role of angiogenesis in hepatocellular carcinoma. Clin. Cancer Res. 25, 912-920. DOI |
42 | McGrath, N.A., Fu, J., Gu, S.Z., and Xie, C. (2020). Targeting cancer stem cells in cholangiocarcinoma (Review). Int. J. Oncol. 57, 397-408. DOI |
43 | Mittal, V. (2018). Epithelial mesenchymal transition in tumor metastasis. Annu. Rev. Pathol. 13, 395-412. DOI |
44 | Miyazaki, K., Oyanagi, J., Hoshino, D., Togo, S., Kumagai, H., and Miyagi, Y. (2019). Cancer cell migration on elongate protrusions of fibroblasts in collagen matrix. Sci. Rep. 9, 292. |
45 | Oakley, A.E., Clifton, D.K., and Steiner, R.A. (2009). Kisspeptin signaling in the brain. Endocr. Rev. 30, 713-743. DOI |
46 | Ogunwobi, O.O., Harricharran, T., Huaman, J., Galuza, A., Odumuwagun, O., Tan, Y., Ma, G.X., and Nguyen, M.T. (2019). Mechanisms of hepatocellular carcinoma progression. World J. Gastroenterol. 25, 2279-2293. DOI |
47 | Ohtaki, T., Shintani, Y., Honda, S., Matsumoto, H., Hori, A., Kanehashi, K., Terao, Y., Kumano, S., Takatsu, Y., Masuda, Y., et al. (2001). Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor. Nature 411, 613-617. DOI |
48 | Pandit, H., Li, Y., Li, X., Zhang, W., Li, S., and Martin, R.C.G. (2018). Enrichment of cancer stem cells via beta-catenin contributing to the tumorigenesis of hepatocellular carcinoma. BMC Cancer 18, 783. |
49 | Perugorria, M.J., Olaizola, P., Labiano, I., Esparza-Baquer, A., Marzioni, M., Marin, J.J.G., Bujanda, L., and Banales, J.M. (2019). Wnt-betacatenin signalling in liver development, health and disease. Nat. Rev. Gastroenterol. Hepatol. 16, 121-136. DOI |
50 | Puisieux, A., Brabletz, T., and Caramel, J. (2014). Oncogenic roles of EMTinducing transcription factors. Nat. Cell Biol. 16, 488-494. DOI |
51 | Qian, H., Yang, L., Zhao, W., Chen, H., and He, S. (2018). A comparison of CD105 and CD31 expression in tumor vessels of hepatocellular carcinoma by tissue microarray and flow cytometry. Exp. Ther. Med. 16, 2881-2888. DOI |
52 | Rathod, K., Sheth, R., Shah, P., and Rege, S. (2000). Active contrast extravasation in spontaneous rupture of hepatocellular carcinoma: a rare CT finding. J. Postgrad. Med. 46, 35-36. |
53 | Rivadeneira, D.B., Mayhew, C.N., Thangavel, C., Sotillo, E., Reed, C.A., Grana, X., and Knudsen, E.S. (2010). Proliferative suppression by CDK4/6 inhibition: complex function of the retinoblastoma pathway in liver tissue and hepatoma cells. Gastroenterology 138, 1920-1930. DOI |
54 | Schmid, K., Wang, X., Haitel, A., Sieghart, W., Peck-Radosavljevic, M., Bodingbauer, M., Rasoul-Rockenschaub, S., and Wrba, F. (2007). KiSS-1 overexpression as an independent prognostic marker in hepatocellular carcinoma: an immunohistochemical study. Virchows Arch. 450, 143-149. DOI |
55 | Shengbing, Z., Feng, L.J., Bin, W., Lingyun, G., and Aimin, H. (2009). Expression of KiSS-1 gene and its role in invasion and metastasis of human hepatocellular carcinoma. Anat. Rec. (Hoboken) 292, 1128-1134. DOI |
56 | Stathaki, M., Stamatiou, M.E., Magioris, G., Simantiris, S., Syrigos, N., Dourakis, S., Koutsilieris, M., and Armakolas, A. (2019). The role of kisspeptin system in cancer biology. Crit. Rev. Oncol. Hematol. 142, 130-140. DOI |
57 | Takeda, A., Stoeltzing, O., Ahmad, S.A., Reinmuth, N., Liu, W., Parikh, A., Fan, F., Akagi, M., and Ellis, L.M. (2002). Role of angiogenesis in the development and growth of liver metastasis. Ann. Surg. Oncol. 9, 610-616. DOI |
58 | Wang, Z., Cui, X., Hao, G., and He, J. (2021). Aberrant expression of PI3K/ AKT signaling is involved in apoptosis resistance of hepatocellular carcinoma. Open Life Sci. 16, 1037-1044. DOI |
59 | Terasawa, E., Guerriero, K.A., and Plant, T.M. (2013). Kisspeptin and puberty in mammals. Adv. Exp. Med. Biol. 784, 253-273. DOI |
60 | Tiwari, N., Gheldof, A., Tatari, M., and Christofori, G. (2012). EMT as the ultimate survival mechanism of cancer cells. Semin. Cancer Biol. 22, 194-207. DOI |
61 | Wen, X., Wu, Y., Awadasseid, A., Tanaka, Y., and Zhang, W. (2020). New advances in canonical Wnt/beta-catenin signaling in cancer. Cancer Manag. Res. 12, 6987-6998. |
62 | Wu, Y. and Zhou, B.P. (2008). New insights of epithelial-mesenchymal transition in cancer metastasis. Acta Biochim. Biophys. Sin. (Shanghai) 40, 643-650. DOI |
63 | Yang, J. and Weinberg, R.A. (2008). Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev. Cell 14, 818-829. DOI |
64 | Yang, J.D., Nakamura, I., and Roberts, L.R. (2011). The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets. Semin. Cancer Biol. 21, 35-43. DOI |
65 | Yoon, S., Shin, B., and Woo, H.G. (2021). Endoplasmic reticulum stress induces CAP2 expression promoting epithelial-mesenchymal transition in liver cancer cells. Mol. Cells 44, 569-579. DOI |
66 | Yuan, K., Xie, K., Lan, T., Xu, L., Chen, X., Li, X., Liao, M., Li, J., Huang, J., Zeng, Y., et al. (2020). TXNDC12 promotes EMT and metastasis of hepatocellular carcinoma cells via activation of beta-catenin. Cell Death Differ. 27, 1355-1368. DOI |
67 | Zhu, X.D., Tang, Z.Y., and Sun, H.C. (2020). Targeting angiogenesis for liver cancer: past, present, and future. Genes Dis. 7, 328-335. DOI |
68 | Zhang, T., Zhang, L., Gao, Y., Wang, Y., Liu, Y., Zhang, H., Wang, Q., Hu, F., Li, J., Tan, J., et al. (2021). Role of aneuploid circulating tumor cells and CD31(+)CD31(+) circulating tumor endothelial cells in predicting and monitoring anti-angiogenic therapy efficacy in advanced NSCLC. Mol. Oncol. 15, 2891-2909. DOI |
69 | Zhang, Y.Y., Kong, L.Q., Zhu, X.D., Cai, H., Wang, C.H., Shi, W.K., Cao, M.Q., Li, X.L., Li, K.S., Zhang, S.Z., et al. (2018). CD31 regulates metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma via the ITGB1-FAK-Akt signaling pathway. Cancer Lett. 429, 29-40. DOI |
70 | Zhu, G.J., Song, P.P., Zhou, H., Shen, X.H., Wang, J.G., Ma, X.F., Gu, Y.J., Liu, D.D., Feng, A.N., Qian, X.Y., et al. (2018). Role of epithelial-mesenchymal transition markers E-cadherin, N-cadherin, beta-catenin and ZEB2 in laryngeal squamous cell carcinoma. Oncol. Lett. 15, 3472-3481. |
71 | Behrooz, A.B. and Syahir, A. (2021). Could we address the interplay between CD133, Wnt/beta-catenin, and TERT signaling pathways as a potential target for glioblastoma therapy? Front. Oncol. 11, 642719. |
72 | Adimoolam, S., Lin, C.X., and Ford, J.M. (2001). The p53-regulated cyclindependent kinase inhibitor, p21 (cip1, waf1, sdi1), is not required for global genomic and transcription-coupled nucleotide excision repair of UV-induced DNA photoproducts. J. Biol. Chem. 276, 25813-25822. DOI |
73 | Aman, A. and Piotrowski, T. (2008). Wnt/beta-catenin and Fgf signaling control collective cell migration by restricting chemokine receptor expression. Dev. Cell 15, 749-761. DOI |
74 | Barzegar Behrooz, A., Syahir, A., and Ahmad, S. (2019). CD133: beyond a cancer stem cell biomarker. J. Drug Target. 27, 257-269. DOI |